Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


01.05.2017

4 Aliment Pharmacol Ther
1 Dig Dis Sci
3 Inflamm Bowel Dis
1 J Crohns Colitis
1 N Engl J Med


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. RODA G, Narula N, Pinotti R, Skamnelos A, et al
    Systematic review with meta-analysis: proximal disease extension in limited ulcerative colitis.
    Aliment Pharmacol Ther. 2017 Apr 27. doi: 10.1111/apt.14063.
    PubMed     Text format     Abstract available

  2. BYE WA, Jairath V, Travis SPL
    Systematic review: the safety of vedolizumab for the treatment of inflammatory bowel disease.
    Aliment Pharmacol Ther. 2017 Apr 27. doi: 10.1111/apt.14075.
    PubMed     Text format     Abstract available

  3. ROBLIN X, Boschetti G, Williet N, Nancey S, et al
    Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial.
    Aliment Pharmacol Ther. 2017 Apr 27. doi: 10.1111/apt.14106.
    PubMed     Text format     Abstract available

  4. COUGHLAN A, Wylde R, Lafferty L, Quinn S, et al
    A rising incidence and poorer male outcomes characterise early onset paediatric inflammatory bowel disease.
    Aliment Pharmacol Ther. 2017 Apr 27. doi: 10.1111/apt.14070.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  5. SAEZ-GONZALEZ E, Moret I, Alvarez-Sotomayor D, Diaz-Jaime FC, et al
    Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Apr 21. doi: 10.1007/s10620-017-4577.
    PubMed     Text format     Abstract available


    Inflamm Bowel Dis

  6. BUHL S, Steenholdt C, Rasmussen M, Borghede MK, et al
    Outcomes After Primary Infliximab Treatment Failure in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001117.
    PubMed     Text format     Abstract available

  7. JACOB V, Crawford C, Cohen-Mekelburg S, Viladomiu M, et al
    Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001132.
    PubMed     Text format     Abstract available

  8. MAGNUSSON MK, Strid H, Isaksson S, Simren M, et al
    The Mucosal Antibacterial Response Profile and Fecal Microbiota Composition Are Linked to the Disease Course in Patients with Newly Diagnosed Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001130.
    PubMed     Text format     Abstract available


    J Crohns Colitis

  9. HARKIN G, Keogh A, Slattery E
    The Effect of Biosimilars (Inflectra(R),) in the management of Acute Severe Ulcerative Colitis.
    J Crohns Colitis. 2017 Apr 24. doi: 10.1093.
    PubMed     Text format    


    N Engl J Med

  10. KNIELING F, Neufert C, Hartmann A, Claussen J, et al
    Multispectral Optoacoustic Tomography for Assessment of Crohn's Disease Activity.
    N Engl J Med. 2017;376:1292-1294.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: